IMvigor210: Updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC) Meeting Abstract
| Authors: | Bellmunt, J.; Balar, A.; Galsky, M. D.; Loriot, Y.; Theodore, C.; Pulido, E. G.; Castellano, D.; Retz, M.; Niegisch, G.; Bracarda, S.; Necchi, A.; Vaishampayan, U.; Sridhar, S.; Eigl, B. J.; Hussain, S.; van der Heijden, M.; Danner, B.; Mariathasan, S.; Legrand, F.; Rosenberg, J. E. |
| Abstract Title: | IMvigor210: Updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi270 |
| Language: | English |
| ACCESSION: | WOS:000393912500778 |
| DOI: | 10.1093/annonc/mdw373.10 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 782PD -- Source: Wos |
